RobertLDupontMD
Psychiatry • Rockville, MDAddiction
Professor, Psychiatry, Georgetown University School of Medicine
Dr. Dupont is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6191 Executive Blvd
Rockville, MD 20852Phone+1 301-231-9010
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1964 - 1966
Mount Sinai Medical Center of ClevelandInternship, Transitional Year, 1963 - 1964
Harvard Medical SchoolClass of 1963
Certifications & Licensure
CA State Medical License 1968 - Present
ME State Medical License 1990 - 2026
MD State Medical License 1968 - 2024- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEssential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion.Lisa J Merlo, Michael D Campbell, Corinne Shea, William White, Gregory E Skipper
The American Journal on Addictions. 2022-03-01 - 124 citationsPolysubstance use in the U.S. opioid crisisWilson M. Compton, Rita J. Valentino, Robert L. DuPont
Molecular Psychiatry. 2021-01-01 - Controlled Substances in the Polydrug Epidemic: Response to Diller.Robert L. DuPont, Amelia M. Arria
The American Journal of Psychiatry. 2019-01-01
Other
- Cannabis use disorders: Clinical features and diagnosisDuPont RL, Bailey JA, Teitelbaum SA
http://www.uptodate.com/contents/cannabis-use-disorders-clinical-features-and-diagnosis
UpToDate, Wolters Kluwer Health - 2012-04-10 - Cannabis use disorders: Epidemiology, comorbidity, and pathogenesisDuPont RL, Bailey JA, Teitelbaum SA
http://www.uptodate.com/contents/cannabis-use-disorders-epidemiology-comorbidity-and-pathogenesis
UpToDate, Wolters Kluwer Health - 2011-07-11 - Cannabis use disorders: Treatment, prognosis, and long-term medical effectsDuPont RL, Bailey JA, Teitelbaum SA
http://www.uptodate.com/contents/cannabis-use-disorders-treatment-prognosis-and-long-term-medical-ef
UpToDate, Wolters Kluwer Health - 2012-12-13 - Join now to see all
Press Mentions
Congress Debates Marijuana Legalization and Impaired DrivingJuly 12th, 2018
Non-Addictive Pain Medication Changing Therapy for Substance Use DisordersApril 1st, 2018
For Addicted Doctors, Confidential Treatment That WorksNovember 7th, 2017- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
